The purchase boosted CBI's stake in the company to 23.09%.
Clal Biotechnology Industries Ltd. (TASE: CBI) has increased its stake in Biocancell Therapeutics Ltd. (TASE:BICL). CBI bought 650,000 Biocancell shares at NIS 3.52 per share for a total of NIS 2.3 million. The purchase boosted CBI's stake in the company to 23.09%.
Biocancell closed at NIS 3.32 yesterday. It opened at NIS 3.37 this morning but fell 1.4% by midday.
Published by Globes [online], Israel business news - www.globes-online.com - on March 13, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008